These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 25623994)
1. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma. Finotello R; Stefanello D; Zini E; Marconato L Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006). Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma. Matsuyama A; Poirier VJ; Mantovani F; Foster RA; Mutsaers AJ J Am Anim Hosp Assoc; 2017; 53(6):304-312. PubMed ID: 28892429 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma. Wiley JL; Rook KA; Clifford CA; Gregor TP; Sorenmo KU Vet Comp Oncol; 2010 Sep; 8(3):221-33. PubMed ID: 20691029 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology. Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441 [TBL] [Abstract][Full Text] [Related]
6. Treatment with DAV for advanced-stage hemangiosarcoma in dogs. Dervisis NG; Dominguez PA; Newman RG; Cadile CD; Kitchell BE J Am Anim Hosp Assoc; 2011; 47(3):170-8. PubMed ID: 21498593 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. Sorenmo KU; Jeglum KA; Helfand SC J Vet Intern Med; 1993; 7(6):370-6. PubMed ID: 8114034 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma. Sorenmo KU; Baez JL; Clifford CA; Mauldin E; Overley B; Skorupski K; Bachman R; Samluk M; Shofer F J Vet Intern Med; 2004; 18(2):209-13. PubMed ID: 15058772 [TBL] [Abstract][Full Text] [Related]
9. VAC protocol for treatment of dogs with stage III hemangiosarcoma. Alvarez FJ; Hosoya K; Lara-Garcia A; Kisseberth W; Couto G J Am Anim Hosp Assoc; 2013; 49(6):370-7. PubMed ID: 24051260 [TBL] [Abstract][Full Text] [Related]
10. Surgery and doxorubicin in dogs with hemangiosarcoma. Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871 [TBL] [Abstract][Full Text] [Related]
11. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma. Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540 [TBL] [Abstract][Full Text] [Related]
12. Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014). Batschinski K; Nobre A; Vargas-Mendez E; Tedardi MV; Cirillo J; Cestari G; Ubukata R; Dagli MLZ Can Vet J; 2018 Sep; 59(9):967-972. PubMed ID: 30197439 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study. Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259 [TBL] [Abstract][Full Text] [Related]
14. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs. Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397 [TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines. Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011. Burton JH; Powers BE; Biller BJ Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712 [TBL] [Abstract][Full Text] [Related]
17. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004). Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000 [TBL] [Abstract][Full Text] [Related]
18. A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma. Finotello R; Henriques J; Sabattini S; Stefanello D; Felisberto R; Pizzoni S; Ferrari R; Marconato L Vet Comp Oncol; 2017 Jun; 15(2):493-503. PubMed ID: 26792231 [TBL] [Abstract][Full Text] [Related]